Humer Kristian 4
4 · Viridian Therapeutics, Inc.\DE · Filed Jan 3, 2022
Insider Transaction Report
Form 4
Humer Kristian
CFO and CBO
Transactions
- Award
Stock Option (Right to Buy)
2021-12-31+121,371→ 121,371 totalExercise: $19.77Exp: 2031-12-31→ Common Stock (121,371 underlying)
Footnotes (1)
- [F1]The option vests 25% on July 26, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.